Human Perception of Odors and Odor Blockers

Last updated: December 3, 2024
Sponsor: Tim McClintock
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Odorants

Clinical Study ID

NCT06191419
43123
1K18DC020155
  • Ages 18-60
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this clinical trial is to determine whether blockers of perception of key odorants in cigarette smoke have any utility in smoking cessation. The main question it aims to answer is:

• Can odor blockers be used to suppress perception of the intensity of cigarette smoke in ways that reduce the ability of the odor of cigarette smoke to increase the urge to smoke.

Participants will be asked to smell up to 20 odor samples per session and report on odor pleasantness and desire to smoke.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Smoker

Exclusion

Exclusion Criteria:

  • Non Smoker

  • Self reported inability to smell or taste

Study Design

Total Participants: 40
Treatment Group(s): 1
Primary Treatment: Odorants
Phase:
Study Start date:
April 05, 2024
Estimated Completion Date:
December 31, 2025

Study Description

The experimental treatments include controls (clean air, irrelevant odor), blocking odors, cigarette smoke odor, and cigarette smoke odor mixed with blocking odors or irrelevant odor. To obtain cigarette smoke odor a 1 inch length of a 1R6F research cigarette is burned to completion in a sealed 5 gallon chamber fitted with septa. Using a syringe fit with a needle and filter, 60 mL aliquots of smoke odor are obtained. These smoke odor aliquots, along with blocking odors, are injected into odor sample bags fit with a septum and a valve that can be attached to the CPAP nose mask worn by each participating smoker. Participants open the valve, inhale once through the nose, close the valve, and then remove the bag from the mask before reporting odor pleasantness and the desire to smoke. A 2 - 3 min wait period is enforced between each odor presentation to prevent odor adaptation and to allow acute motivational effects to subside.

In a testing session a participant sniffs 4 concentrations of a mixture of 2 blocking odors, along with control odor samples. Presentation order is randomized. Each participant is assigned their own CPAP nose mask, and masks are disinfected after use. Participants also provide demographic (age, sex, ethnic and racial background) and smoking history information (cigarettes per day, preferred brand, age at onset, and time since last cigarette).

Connect with a study center

  • University of Kentucky

    Lexington, Kentucky 40536
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.